EL
Erick Lucera
Chief Financial Officer

Erick Lucera insider trades: Dyne Therapeutics (DYN) stock buys and sales

Chief Financial Officer, Dyne Therapeutics Last trade Aug 13, 2026 37 Form 4 filings
$181K
Sold, last 12 months
3 sales
$0
Bought, last 12 months
0 buys
9
Open-market trades
since 2017
8
Companies
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Erick reports to the SEC

and 2 more companies

Open-market buys and sales

9 trades reported on SEC Form 4, newest first

DateStockTypeValue
Aug 13, 2026DYN↓ Sell$47K
May 13, 2026DYN↓ Sell$27K
Apr 1, 2026DYN↓ Sell$107K
Mar 4, 2025EDIT↓ Sell$7K
Aug 14, 2024XAIR↑ Buy$16K
May 20, 2024EDIT↓ Sell$125K
Mar 16, 2023XAIR↑ Buy$14K
May 22, 2017VLRX↑ Buy$7K
Mar 23, 2017VLRX↑ Buy$30K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other DYN insiders

Open-market trades in the last 12 months

About Erick Lucera's insider trades

Erick Lucera is Chief Financial Officer at Dyne Therapeutics (DYN). Since Mar 23, 2017, Erick has reported 4 open-market purchases worth $67K and 5 sales worth $313K on SEC Form 4. In the last 12 months: 3 sales ($181K).

Their filings also include grants and awards (26 filings), shares returned to the company (3 filings), option exercises (2 filings), other transactions (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every DYN insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.